Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Today tags : Approval save search
First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: -0.03%
H: 2.66%
C: 2.46%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.82%
H: 0.37%
C: 0.17%
XOMA | $25.11 -3.76% -3.9% 8.2K
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: -1.91%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
rare first opioid approval for
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
AMRX | $6.07 12.41% 11.04% 3.1M
|
Health Technology
|
| O: 6.67%
H: 6.08%
C: 5.03%
fda opioid approval treatment for spray
Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
XOMA | $25.11 -3.76% -3.9% 8.2K
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: -1.91%
day fda approval tumor for
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.